生物製药塑胶市场－全球产业规模、份额、趋势、机会和预测，按聚合物类型（聚氯乙烯、聚对苯二甲酸乙二酯、聚丙烯等）、应用、地区和竞争情况细分，2020-2030 年预测

2024 年生物製药塑胶市场价值为 54.7 亿美元，预计到 2030 年将达到 73.4 亿美元，复合年增长率为 5.23%。

全球生物製药塑胶市场正经历转型期，这得益于生物製药领域对先进材料日益增长的需求。生物製药塑料，包括聚乙烯、聚丙烯和聚碳酸酯等聚合物，是一次性生物处理系统、包装、实验室器皿和药物传输系统等应用不可或缺的一部分。这些材料因其耐化学性、无菌性和耐用性而备受推崇，是确保产品安全性和有效性不可或缺的关键材料。随着生物製药公司越来越多地采用一次性技术来降低污染风险并提高营运灵活性，生物製药塑胶市场发展势头强劲，这种转变在后疫情时代尤为明显，人们更加重视卫生生产规范。

生物製药生产日益复杂，推动了市场的发展。创新的药物输送机制和个人化医疗需要能够满足严格监管标准的材料。生物製药塑胶与控释系统和保护性包装的整合，进一步拓展了其用途，满足了全球慢性病发病率上升和人口老化日益加剧的挑战。这种人口趋势，加上医疗支出的增加，正在培育强劲的需求环境。对永续解决方案的追求正在影响市场动态，利害关係人正在探索环保塑胶替代品，以符合全球环境目标。

关键市场驱动因素

一次性生物处理系统需求不断成长

主要市场挑战

原物料价格波动

主要市场趋势

转向可持续和可回收塑料

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：干扰：衝突、流行病与贸易壁垒

第五章：全球生物製药塑胶市场展望

• 市场规模和预测
  • 按价值和数量
• 市场占有率和预测
  • 依聚合物类型（聚氯乙烯 (PVC)、聚对苯二甲酸乙二酯(PET)、聚丙烯 (PP)、其他）
  • 按应用（防护服、容器、生物反应器袋、注射器、其他）
  • 按地区
  • 按公司分类（2024 年）
• 市场地图
  • 按聚合物类型
  • 按应用
  • 按地区

第六章：北美生物製药塑胶市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲生物製药塑胶市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 西班牙
  • 义大利

第八章：亚太生物製药塑胶市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲生物製药塑胶市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲生物製药塑胶市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 产品发布
• 併购
• 技术进步

第 13 章：全球生物製药塑胶市场：SWOT 分析

第 14 章：定价分析

第 15 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 16 章：竞争格局

• Saudi Basic Industries Corporation
• BASF SE
• Spectrum Plastics Group
• Celanese Corporation
• LyondellBasell Industries Holdings BV
• DuPont de Nemours, Inc.
• Tekni-Plex, Inc.
• Solvay SA
• Avantor, Inc.
• Bormioli Pharma SpA

第 17 章：策略建议

第18章调查会社について・免责事项

Biopharma Plastics Market was valued at USD 5.47 Billion in 2024 and is expected to reach USD 7.34 Billion by 2030 with a CAGR of 5.23%.

The global biopharma plastics market is witnessing a transformative phase, driven by the escalating demand for advanced materials in the biopharmaceutical sector. Biopharma plastics, encompassing polymers such as polyethylene, polypropylene, and polycarbonate, are integral to applications including single-use bioprocessing systems, packaging, laboratory ware, and drug delivery systems. These materials are valued for their chemical resistance, sterility, and durability, making them indispensable in ensuring product safety and efficacy. The market has gained momentum as biopharmaceutical companies increasingly adopt single-use technologies to mitigate contamination risks and enhance operational flexibility, a shift that has been particularly pronounced in the post-pandemic era with heightened focus on hygienic manufacturing practices.

The market's evolution is underpinned by the growing complexity of biopharmaceutical production, where innovative drug delivery mechanisms and personalized medicine require materials that can withstand stringent regulatory standards. The integration of biopharma plastics in controlled release systems and protective packaging has further expanded their utility, catering to the rising prevalence of chronic diseases and the aging global population. This demographic trend, coupled with increased healthcare expenditure, is fostering a robust demand environment. The push towards sustainable solutions is influencing market dynamics, with stakeholders exploring eco-friendly plastic alternatives to align with global environmental goals.

Key Market Drivers

Rising Demand for Single-Use Bioprocessing Systems

The global biopharma plastics market is significantly driven by the increasing adoption of single-use bioprocessing systems, which have revolutionized manufacturing processes in the biopharmaceutical industry. These systems, utilizing plastics such as polyethylene and polypropylene, offer a cost-effective and contamination-free alternative to traditional stainless-steel setups, aligning with the industry's focus on enhancing production efficiency and safety. The shift towards single-use technologies has been accelerated by the need to reduce cross-contamination risks, a critical concern in the production of biologics and vaccines. This trend is particularly evident in the wake of global health crises, which have underscored the importance of scalable and flexible manufacturing solutions.

The demand is further supported by the growing complexity of biopharmaceutical products, including monoclonal antibodies and gene therapies, which require sterile and disposable components. Regulatory bodies worldwide are endorsing these systems, encouraging their widespread adoption through favorable guidelines. Additionally, the reduced need for extensive cleaning and validation processes associated with single-use systems translates into lower operational costs and faster turnaround times, appealing to both large-scale manufacturers and emerging biotech firms. As the biopharma sector continues to expand its pipeline, the reliance on these plastic-based solutions is expected to grow, fuelling market expansion throughout the 2020-2030F forecast period.

Key Market Challenges

Volatility in Raw Material Prices

The biopharma plastics market faces a significant challenge due to the volatility in raw material prices, which impacts production costs and profit margins. Polymers such as polyethylene and polypropylene are derived from petrochemical sources, making their prices susceptible to fluctuations in crude oil markets. This instability creates uncertainty for manufacturers, who must navigate unpredictable cost structures while maintaining competitive pricing. The challenge is compounded by the need to source high-quality raw materials that meet stringent regulatory standards, further increasing expenses during price surges.

This volatility can disrupt supply chains, leading to delays in production and potential shortages of critical components. For small and medium-sized enterprises, the inability to absorb these cost fluctuations poses a risk to their market presence. Industry players are compelled to explore alternative sourcing strategies or invest in price stabilization measures, which may require significant capital investment. Addressing this challenge will be crucial to ensuring the market's resilience over the 2020-2030F period.

Key Market Trends

Shift Towards Sustainable and Recyclable Plastics

A prominent trend in the biopharma plastics market is the shift towards sustainable and recyclable plastics, driven by increasing environmental consciousness and regulatory pressures. Manufacturers are investing in the development of bio-based polymers and recyclable materials that maintain the necessary properties for biopharmaceutical applications, such as sterility and chemical resistance. This trend aligns with global sustainability initiatives, encouraging the adoption of lightweight plastics that reduce carbon footprints during production and disposal.

The move towards eco-friendly solutions is also influencing consumer preferences, with healthcare providers and biopharma companies seeking greener alternatives to traditional plastics. This trend is expected to gain traction over the 2020-2030F period, as innovations in material science pave the way for scalable, sustainable options that meet industry standards.

Key Market Players

• Saudi Basic Industries Corporation
• BASF SE
• Spectrum Plastics Group
• Celanese Corporation
• LyondellBasell Industries Holdings B.V.
• DuPont de Nemours, Inc.
• Tekni-Plex, Inc.
• Solvay S.A.
• Avantor, Inc.
• Bormioli Pharma S.p.A.

Report Scope

In this report, the Global Biopharma Plastics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biopharma Plastics Market, By Polymer Type:

• Polyvinyl Chloride (PVC)
• Polyethylene
• Terephthalate (PET)
• Polypropylene (PP)
• Others

Biopharma Plastics Market, By Application:

• Protective Wear
• Containers
• Bioreactor Bags
• Syringes
• Others

Biopharma Plastics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biopharma Plastics Market.

Available Customizations:

Global Biopharma Plastics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Disruptions: Conflicts, Pandemics, and Trade Barriers

5. Global Biopharma Plastics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Polymer Type (Polyvinyl Chloride (PVC), Polyethylene Terephthalate (PET), Polypropylene (PP), Others)
  • 5.2.2. By Application (Protective Wear, Containers, Bioreactor Bags, Syringes, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Polymer Type
  • 5.3.2. By Application
  • 5.3.3. By Region

6. North America Biopharma Plastics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value & Volume
• 6.2. Market Share & Forecast
  • 6.2.1. By Polymer Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biopharma Plastics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value & Volume
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Polymer Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Biopharma Plastics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value & Volume
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Polymer Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Biopharma Plastics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value & Volume
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Polymer Type
      • 6.3.3.2.2. By Application

7. Europe Biopharma Plastics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value & Volume
• 7.2. Market Share & Forecast
  • 7.2.1. By Polymer Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Biopharma Plastics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value & Volume
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Polymer Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Biopharma Plastics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value & Volume
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Polymer Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Biopharma Plastics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value & Volume
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Polymer Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Spain Biopharma Plastics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value & Volume
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Polymer Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Italy Biopharma Plastics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value & Volume
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Polymer Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Biopharma Plastics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value & Volume
• 8.2. Market Share & Forecast
  • 8.2.1. By Polymer Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Biopharma Plastics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value & Volume
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Polymer Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Biopharma Plastics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value & Volume
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Polymer Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Biopharma Plastics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value & Volume
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Polymer Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Biopharma Plastics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value & Volume
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Polymer Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Biopharma Plastics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value & Volume
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Polymer Type
      • 8.3.5.2.2. By Application

9. South America Biopharma Plastics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value & Volume
• 9.2. Market Share & Forecast
  • 9.2.1. By Polymer Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Biopharma Plastics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value & Volume
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Polymer Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Biopharma Plastics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value & Volume
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Polymer Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Biopharma Plastics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value & Volume
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Polymer Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Biopharma Plastics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value & Volume
• 10.2. Market Share & Forecast
  • 10.2.1. By Polymer Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Biopharma Plastics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value & Volume
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Polymer Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Biopharma Plastics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value & Volume
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Polymer Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Biopharma Plastics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value & Volume
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Polymer Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Product Launches
• 12.2. Mergers & Acquisitions
• 12.3. Technological Advancements

13. Global Biopharma Plastics Market: SWOT Analysis

14. Pricing Analysis

15. Porter's Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Saudi Basic Industries Corporation
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In Case of Listed Companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. BASF SE
• 16.3. Spectrum Plastics Group
• 16.4. Celanese Corporation
• 16.5. LyondellBasell Industries Holdings B.V.
• 16.6. DuPont de Nemours, Inc.
• 16.7. Tekni-Plex, Inc.
• 16.8. Solvay S.A.
• 16.9. Avantor, Inc.
• 16.10. Bormioli Pharma S.p.A.

17. Strategic Recommendations

18. About Us & Disclaimer